Topic: Hepatitis

Liver disease that is tied to HCV infection is a leading cause of death among HIV-infected individuals. Ryan White-funded clinics are taking on a greater role in not only managing HCV disease but also providing HCV treatments, which was once considered too toxic and risky but is less so given new and emerging HCV drug regimens.

Filter resources by:

Guidelines and Manuals

Webinars and Training

  • AETC National Resource Center
    January 2014

    Clinical education/training resources and patient education materials from the HRSA AETC network.

  • AETC National Resource Center
    January 2014

    Clinician training resources and tools such as pocket guides, wall charts, and patient education fact sheets developed by the HRSA AIDS Education and Training Centers network. Includes comprehensive training slides to accompany HHS guidelines.

  • University of Washington
    May 2013

    Self-study online course on Hepatitis C infection for medical providers with modules, slide lectures, core concepts, and bibiliography.

  • New York/New Jersey AETC

    Online learning module for healthcare professionals tp learn more about caring for people living with HIV.

Tools and Job Aids

  • Florida Department of Health
    September 2013

    Pocket guide to help clinicians in the diagnosis and management of chronic hepatitis C virus (HCV) infection in HIV-coinfected patients. This guide:

  • HRSA HIV/AIDS Bureau
    January 2011

    Guide presents a rationale for why Ryan White clinics should play a greater role in HCV treatment and steps they can take in deciding how to integrate HCV treatment within their HIV/AIDS primary care services.

  • Alameda County Medical Center
    June 2006

    Graphic flowchart presents Alameda County Medical Center treatment decision tree for HIV/hepatitis C visrus (HCV) coinfection.

Reports and Best Practices

  • Clinical Infectious Diseases
    June 2014

    In the United States, of the 1.1 million persons infected with human immunodeficiency virus (HIV) and the 2.7 million infected with hepatitis C virus (HCV), approximately 16% and 50%, respectively, are unaware of their infection. Highly effective treatments have turned both diseases into manageable conditions, and in the case of hepatitis C, a disease that can be cured.


  • New York State Department of Health AIDS Institute
    January 2015

    HIV guidelines, quality of care, clinical education, resources, policies and publications.

  • American Association for the Study of Liver Diseases (AASLD), Infectious Diseases Society of America (IDSA), International Antiviral Society - USA (IAS-USA)
    October 2014

    Guidance on use of direct-acting oral agents approved for use in treating and curing hepatitis C.